Cardiovascular Systems today announced that it has acquired a line of peripheral support catheters from WavePoint Medical for an undisclosed amount.
Through the acquisition, WavePoint will also develop specialty catheters for treating chronic total occlusions and complex percutaneous coronary intervention procedures for Cardiovascular Systems. The company expects availability for the specialty catheters in Cardiovascular System’s fiscal year ending June 30, 2023.
“With the acquisition of these peripheral support catheters, CSI will soon offer a complete portfolio of products for the treatment of peripheral artery disease, including atherectomy, balloon catheters, guide wires, support catheters and embolic protection,” Cardiovascular Systems president and CEO Scott Ward said in a news release. “In coronary, the successful development of a portfolio of CTO products will expand our existing offering of coronary support products. Together, these new products advance our ability to help physicians improve outcomes for patients undergoing complex peripheral and coronary interventions.”
Peripheral support catheters are used during peripheral vascular intervention (PVI) procedures for guidewire support. Support catheters are used in approximately 50% of PVIs, mostly in below-the-knee and complex interventions.
